Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularisation secondary to pathological myopia.

The treatment of choroidal neovascularisation (CNV) secondary to pathological myopia has presented a number of problems to ophthalmologists over the years, but the advent of photodynamic therapy (PDT) with verteporfin has changed how we manage these patients.Until PDT became available, the use of laser photocoagulation for extra and juxtafoveal lesions had been shown to be effective in the short term in preventing loss of vision, although the risk of regrowth of CNV and undertreatment were well recognised. However, even in apparent successful cases of photocoagulation, laser scar enlargement and creepage into the fovea in the mid-to-long term often occurred with resulting loss of central vision. Other options for treatment were very limited with little evidence that other modalities such as transpupillary thermotherapy or submacular surgery and macular transplantation surgery would be successful in highly myopic eyes.

作 者：

Gibson,J

刊 名：

Eye 

年，卷(期)：

2005vol.19(no.8) 

分类号：

 

关键词：

Choroidal Neovascularization  Myopia, Degenerative  Photochemotherapy  Photosensitizing Agents  脉络膜新生血管化  光化学疗法  光敏感药

正文语种：

eng 

基金项目：